analyst presentation

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

[Date of Report: March 19, 2003]

Date of Earliest Event Reported: March 19, 2003

MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)

Delaware 1-12091 22-3436215
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
(I.R.S. Employer
Identification Number)
     
  230 Half Mile Road
Red Bank, New Jersey 07701
 (Address of principal executive offices)  

Registrant's telephone number, including area code: (732) 933-5000


 

Item 7. Financial Statements and Exhibits.
   
  Exhibit   Description
 
  99.1   Investor presentation made March 19, 2003
 
Item 9. Regulation FD Disclosure.
 
  On March 19, 2003, William M. Landuyt, the Chairman and Chief Executive Officer of the registrant made the investor presentation furnished in Exhibit 99.1 as part of Merrill Lynch's chemical conference. The foregoing shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section.

 

 

 

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on behalf of the undersigned hereunto duly authorized.

     Dated: March 19, 2003

  MILLENNIUM CHEMICALS INC.
  By: _/C. William Carmean/_________________________
         C. William Carmean
         Senior Vice President, General Counsel & Secretary

 

 

EXHIBIT INDEX

  Exhibit   Description
 
  99.1   Investor Presentation made March 19, 2003